News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
206,577 Results
Type
Article (6493)
Company Profile (20)
Press Release (200064)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (79158)
Career Advice (464)
Deals (16007)
Drug Delivery (17)
Drug Development (16626)
Employer Resources (31)
FDA (2730)
Job Trends (3918)
News (112669)
Policy (6651)
Tag
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (334)
Accelerated approval (1)
Adcomms (1)
Allergies (15)
Alliances (10678)
ALS (16)
Alzheimer's disease (273)
Antibody-drug conjugate (ADC) (24)
Approvals (2744)
Artificial intelligence (38)
Autoimmune disease (9)
Automation (5)
Bankruptcy (135)
Best Places to Work (3449)
BIOSECURE Act (2)
Biosimilars (17)
Biotechnology (17)
Bladder cancer (13)
Brain cancer (4)
Breast cancer (68)
Cancer (480)
Cardiovascular disease (23)
Career advice (404)
Career pathing (2)
CAR-T (33)
Cell therapy (110)
Cervical cancer (2)
Clinical research (13916)
Collaboration (170)
Compensation (50)
Complete response letters (3)
COVID-19 (408)
CRISPR (6)
C-suite (99)
Cystic fibrosis (27)
Data (526)
Denatured (2)
Depression (8)
Diabetes (71)
Diagnostics (1797)
Digital health (5)
Diversity, equity & inclusion (11)
Drug discovery (29)
Drug pricing (14)
Drug shortages (5)
Duchenne muscular dystrophy (35)
Earnings (46517)
Editorial (13)
Employer branding (2)
Employer resources (29)
Events (40252)
Executive appointments (362)
FDA (3009)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (222)
Gene editing (21)
Gene therapy (56)
GLP-1 (158)
Government (708)
Grass and pollen (1)
Guidances (25)
Healthcare (5879)
Huntington's disease (3)
IgA nephropathy (6)
Immunology and inflammation (27)
Indications (5)
Infectious disease (441)
Inflammatory bowel disease (48)
Influenza (15)
Intellectual property (29)
Interviews (63)
IPO (9166)
IRA (6)
Job creations (587)
Job search strategy (355)
Kidney cancer (4)
Labor market (7)
Layoffs (61)
Leadership (2)
Legal (1766)
Liver cancer (9)
Lung cancer (66)
Lymphoma (25)
Management (7)
Manufacturing (77)
MASH (24)
Medical device (4714)
Medtech (4715)
Mergers & acquisitions (7192)
Metabolic disorders (157)
Multiple sclerosis (17)
NASH (3)
Neurodegenerative disease (19)
Neuropsychiatric disorders (4)
Neuroscience (380)
NextGen: Class of 2025 (1904)
Non-profit (565)
Northern California (987)
Now hiring (3)
Obesity (71)
Opinion (48)
Ovarian cancer (22)
Pain (28)
Pancreatic cancer (24)
Parkinson's disease (34)
Partnered (4)
Patents (66)
Patient recruitment (25)
Peanut (10)
People (20855)
Pharmaceutical (10)
Pharmacy benefit managers (6)
Phase I (4358)
Phase II (6483)
Phase III (4768)
Pipeline (483)
Policy (23)
Postmarket research (313)
Preclinical (1469)
Press Release (18)
Prostate cancer (19)
Psychedelics (8)
Radiopharmaceuticals (106)
Rare diseases (87)
Real estate (1018)
Recruiting (16)
Regulatory (4652)
Reports (19)
Research institute (416)
Resumes & cover letters (58)
Rett syndrome (2)
RSV (7)
Schizophrenia (23)
Series A (46)
Series B (19)
Service/supplier (1)
Sickle cell disease (17)
Southern California (820)
Special edition (3)
Spinal muscular atrophy (24)
Sponsored (8)
Startups (966)
State (2)
Stomach cancer (2)
Supply chain (22)
Tariffs (2)
The Weekly (8)
United States (8677)
Vaccines (119)
Venture capitalists (9)
Weight loss (38)
Women's health (7)
Worklife (2)
Date
Last 7 days (189)
Last 30 days (784)
Last 365 days (12034)
2025 (3585)
2024 (13226)
2023 (15068)
2022 (19111)
2021 (20477)
2020 (18786)
2019 (13541)
2018 (10150)
2017 (9673)
2016 (8629)
2015 (11332)
2014 (8212)
2013 (6182)
2012 (6844)
2011 (6958)
2010 (6212)
Location
Africa (125)
Alabama (18)
Alaska (2)
Arizona (75)
Arkansas (4)
Asia (10905)
Australia (1432)
California (2201)
Canada (668)
China (112)
Colorado (125)
Connecticut (117)
Delaware (42)
Europe (21002)
Florida (356)
Georgia (76)
Idaho (10)
Illinois (138)
India (2)
Indiana (161)
Japan (35)
Kansas (26)
Kentucky (3)
Maine (38)
Maryland (300)
Massachusetts (1712)
Michigan (112)
Minnesota (170)
Mississippi (2)
Missouri (33)
Montana (14)
Nebraska (8)
Nevada (36)
New Hampshire (26)
New Jersey (737)
New Mexico (8)
New York (625)
North Carolina (450)
Northern California (987)
Ohio (68)
Oklahoma (3)
Oregon (4)
Pennsylvania (514)
Puerto Rico (5)
Rhode Island (8)
South America (274)
South Carolina (6)
Southern California (820)
Tennessee (40)
Texas (348)
Utah (72)
Virginia (40)
Washington D.C. (10)
Washington State (181)
West Virginia (2)
Wisconsin (18)
206,577 Results for "replay holdings llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 24, 2024
·
1 min read
Business
Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.
Scilex Holding Company announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC.
June 20, 2024
·
7 min read
Press Releases
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC
January 21, 2025
·
7 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Drug Development
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
March 11, 2024
·
5 min read
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Immunology and inflammation
Vyne Crashes After Safety Signal in Dogs Puts Hold on Clinical Trial of Plaque Psoriasis
The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent observation of testicular toxicity in canines given the treatment.
April 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
1 of 20,658
Next
